# Brinsupri

NDC: 71558-002
Generic name: Brensocatib
Labeler / Manufacturer: Insmed Incorporated
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250812

FDA application: NDA217673

## Active ingredients

- BRENSOCATIB: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71558-002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71558-002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b56986ae-e7db-421e-b622-a7f41e321f3d